|
News Releases
MARRTC researchers present at ACR
Columbia, Mo. (Oct. 25, 2002) - Six researchers from the University of Missouri-Columbia presented at American College of Rheumatology Annual Scientific Meeting this week in New Orleans.
The ACR is the primary professional organization for health-care professionals who treat arthritis - the nation's No. 1 cause of disability. Arthritis affects about 43 million Americans - one of every six people in the nation.
This annual meeting of the ACR typically draws about 7,000 health-care professionals from around the world.
Those presenting include four researchers with the Missouri Arthritis Rehabilitation Research and Training Center (MARRTC). MARRTC is a federally funded center housed at the University of Missouri-Columbia. It is the only such center in the nation.
MARRTC researchers presenting and the topics include:
- Kris Hagglund, Ph.D., of MU's School of Health Professions, will present "Access to Health Care among People with Rheumatoid Arthritis or Osteoarthritis over Two Years."
- John E. Hewett, Ph.D., of MU's ITS Biostatistics, will present a one-half hour workshop on "What are the Dos and Don'ts for Writing an Effective Research Proposal?" This is the 16th ACR meeting at which Hewett has presented a workshop.
- Shelley Hilton, M.A., of MU's Department of Health Psychology, will present "Barriers to Obtaining Health Care Services and their Consequences: A Qualitative Analysis of People with Osteoarthritis and Rheumatoid Arthritis."
- Karen L. Smarr, M.A., of Harry S Truman Memorial Veterans Hospital, will present "Arthritis Continuing Education for Vocational Rehabilitation Counselors."
Two MARRTC-affiliated physicians also will present at the ACR annual meeting.
Eric L. Greidinger, M.D., and Robert W. Hoffman, D.O., of the University of Missouri-Columbia and Harry S Truman Veteran's Administration Hospital, will present "Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A2 is a Target of T Cell Immunity in Systemic Lupus Erythematosus," and "Rna Binding Domain on U1-70kd Small Nuclear Ribonucleoprotein is Target of T Cell Immunity in Connective Tissue Disease Patients."
Greidinger also will present "A Major Apoptosis-Specific B Cell Epitope of the U1-70kd Ribonucleoprotein Autoantigen Overlaps with the RNA Binding Domain of the Protein."
|
|
